Systemic Infusion of Expanded CD133(+) Cells and Expanded CD133(+) Cell-Derived EVs for the Treatment of Ischemic Cardiomyopathy in a Rat Model of AMI

Myocardial infarction is a leading cause of death among all cardiovascular diseases. Cell therapies using a cell population enriched with endothelial progenitor cells (EPCs), expanded CD133(+) cells, have promise as a therapeutic option for the treatment of ischemic areas after infarction. Recently,...

Descripción completa

Detalles Bibliográficos
Autores principales: Angulski, Addeli B. B., Capriglione, Luiz Guilherme A., Barchiki, Fabiane, Brofman, Paulo, Stimamiglio, Marco A., Senegaglia, Alexandra C., Correa, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914904/
https://www.ncbi.nlm.nih.gov/pubmed/31885610
http://dx.doi.org/10.1155/2019/4802578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914904/
https://www.ncbi.nlm.nih.gov/pubmed/31885610
http://dx.doi.org/10.1155/2019/4802578

Ejemplares similares